Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Dallas TX, Houston TX, Aurora CO, Arlington Heights IL,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Dallas TX, St Louis MO, Indianapolis IN, Rochester MN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Plano TX, Abilene TX, Round Rock TX, Austin TX,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04926467
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Analysis of Graft Function Following Autologous Islet Transplantation
for
Chronic Pancreatitis
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT03097185
Recruiting
Teen Recovery Through Inspiration, Support, and Empowerment
for
Suicidal Ideation, Suicide Attempt, Anxiety,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 15 - 18
Code: NCT07170657
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Tyler TX, Shreveport LA, San Antonio TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Denver CO, Nashville TN, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Dallas TX, Round Rock TX, Austin TX, Hot Springs AR,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
for
Non-Small Cell Lung Cancer
Location: Dallas TX, San Antonio TX, Beaumont TX, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07680790
Phase 3, Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Dallas TX, Tyler TX, Little Rock AR, Lincoln NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Location: Dallas TX, Abilene TX, The Woodlands TX, Carmel IN,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07160179
Phase 1, Phase 2, Recruiting
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Dallas TX, Toronto, Montreal, Boston MA
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07570979
Phase 1, Recruiting
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
for
Negative Symptoms of Schizophrenia
Location: Richardson TX, Atlanta GA, Decatur GA, Tampa FL,